|
ParlodelDrug - Parlodel The trade name of the product as shown on the labeling.
Dosage -
TABLET; ORAL
Active Ingredient(s) -
Bromocriptine Mesylate
Strength -
EQ 2.5MG BASE
Applicant -
NOVARTIS
New Drug Application (NDA) Number -
017962
Product Number -
001
Therapeutic Equivalence (TE) Code -
AB
Approval Date -
Approved Prior to Jan 1, 1982
Reference Listed Drug (RLD) -
Yes
Type -
RX
Applicant Full Name -
Novartis Pharmaceuticals Corp
Parlodel
Brimonidine Tartrate 0.2% Solution/drops; Ophthalmic
Azopt 1% Suspension/drops; Ophthalmic Xibrom 0.09% Solution/drops; Ophthalmic Bromocriptine Mesylate Eq 5mg Base Capsule; Oral Bromocriptine Mesylate Eq 5mg Base Capsule; Oral Parlodel Eq 5mg Base Capsule; Oral Bromocriptine Mesylate Eq 2.5mg Base Tablet; Oral Bromocriptine Mesylate Eq 2.5mg Base Tablet; Oral Parlodel Eq 2.5mg Base Tablet; Oral Brimonidine Tartrate 0.2% Solution/drops; Ophthalmic NewDrugInformation |